These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17998914)

  • 1. The regulation of the B-cell gene expression programme by Pax5.
    Holmes ML; Pridans C; Nutt SL
    Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Pax5 target genes in early B cell differentiation.
    Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
    J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.
    Holmes ML; Carotta S; Corcoran LM; Nutt SL
    Genes Dev; 2006 Apr; 20(8):933-8. PubMed ID: 16618805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation in early B cell development.
    Fuxa M; Skok JA
    Curr Opin Immunol; 2007 Apr; 19(2):129-36. PubMed ID: 17292598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.
    Horcher M; Souabni A; Busslinger M
    Immunity; 2001 Jun; 14(6):779-90. PubMed ID: 11420047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid Gene Upregulation on Circulating Progenitors Participates in Their T-Lineage Commitment.
    Zepponi V; Michaels Lopez V; Martinez-Cingolani C; Boudil A; Pasqualetto V; Skhiri L; Gautreau L; Legrand A; Megret J; Zavala F; Ezine S
    J Immunol; 2015 Jul; 195(1):156-65. PubMed ID: 26026063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
    MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
    Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
    Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
    J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
    Revilla-I-Domingo R; Bilic I; Vilagos B; Tagoh H; Ebert A; Tamir IM; Smeenk L; Trupke J; Sommer A; Jaritz M; Busslinger M
    EMBO J; 2012 Jun; 31(14):3130-46. PubMed ID: 22669466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Context-dependent regulation of hematopoietic lineage choice by HEBAlt.
    Wang D; Claus CL; Rajkumar P; Braunstein M; Moore AJ; Sigvardsson M; Anderson MK
    J Immunol; 2010 Oct; 185(7):4109-17. PubMed ID: 20826759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
    Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
    Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.